Table 2.

Comparison of clinical findings at 24 mo after biopsy and at final observation

Parameter24 Mo after BiopsyFinal Observation
Group C (n = 34)Group M (n = 17)PaGroup C (n = 35)Group M (n = 20)Pa
Observation period (mo; mean ± SD)49.3 ± 15.662.4 ± 27.00.060
SBP (mmHg; mean ± SD)117.5 ± 12.8120.9 ± 10.00.364116.2 ± 13.7116.4 ± 18.00.969
DBP (mmHg; mean ± SD)73.0 ± 9.175.2 ± 8.30.43870.5 ± 13.571.8 ± 12.90.721
Patients with BP >140/90 mmHg (n [%])2 (5.9)0 (0.0)0.4772 (5.7)1 (5.0)0.703
Serum creatinine (mg/dl; mean ± SD)0.86 ± 0.221.01 ± 0.910.5170.84 ± 0.281.24 ± 1.820.344
Patients with 100% increased sCr (n [%])0 (0.0)1 (6.7)0.3060 (0.0)1 (5.0)0.364
Disappearance of UP (n [%])26 (76.5)7 (41.2)0.013b23 (65.7)7 (35.0)0.028b
Disappearance of UOB (n [%])27 (79.4)3 (17.6)<0.001b27 (77.1)9 (45.0)0.016b
Remission of urinary abnormalities (n [%])21 (61.8)3 (17.6)<0.001b19 (54.3)5 (25.0)0.033b
  • a Data compared using unpaired t test, χ2 test, and Fisher exact test.

  • b Statistically significant.